pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,466 catalysts · 6,181 phase readout · 2,279 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 60 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,181
  • 8k filing2,279
  • earnings395
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Week of Aug 10, 2026

31
›Aug 13, 20268k filing1d ago$OLMA — Olema Pharmaceuticals, Inc. (OLMA) — 8-K filing

Items: 5.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$ZBIO — Zenas BioPharma, Inc. (ZBIO) — 8-K filing

Items: 2.02, 5.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$VREOF — Vireo Growth Inc. (VREOF) — 8-K filing

Items: 1.01, 2.01, 2.03, 3.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$PTCT — PTC THERAPEUTICS, INC. (PTCT) — 8-K filing

Items: 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$RMTI — ROCKWELL MEDICAL, INC. (RMTI) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$ABEO — ABEONA THERAPEUTICS INC. (ABEO) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$INDP — Indaptus Therapeutics, Inc. (INDP) — 8-K filing

Items: 2.02, 5.07, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$COLL — COLLEGIUM PHARMACEUTICAL, INC (COLL) — 8-K filing

Items: 8.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$CLRB — Cellectar Biosciences, Inc. (CLRB) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$CABA — Cabaletta Bio, Inc. (CABA) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$PULM — Pulmatrix, Inc. (PULM) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$CRMD — CorMedix Inc. (CRMD) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$BJDX — Bluejay Diagnostics, Inc. (BJDX) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$CADL — Candel Therapeutics, Inc. (CADL) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$PYXS — Pyxis Oncology, Inc. (PYXS) — 8-K filing

Items: 2.02

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$INKT — MiNK Therapeutics, Inc. (INKT) — 8-K filing

Items: 2.02

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$KPTI — Karyopharm Therapeutics Inc. (KPTI) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$GRCE — Grace Therapeutics, Inc. (GRCE) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$MGTX — MeiraGTx Holdings plc (MGTX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$OVID — Ovid Therapeutics Inc. (OVID) — 8-K filing

Items: 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$LUCD — Lucid Diagnostics Inc. (LUCD) — 8-K filing

Items: 2.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$SSII — SS Innovations International, Inc. (SSII) — 8-K filing

Items: 2.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$FATE — FATE THERAPEUTICS INC (FATE) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$SINT — Sintx Technologies, Inc. (SINT) — 8-K filing

Items: 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d agoBiofrontera Inc. (BFRI, BFRIW) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d agoCingulate Inc. (CING, CINGW) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$PDSB — PDS Biotechnology Corp (PDSB) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$DWTX — Dogwood Therapeutics, Inc. (DWTX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$ADCT — ADC Therapeutics SA (ADCT) — 8-K filing

Items: 2.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 13, 20268k filing1d ago$CYTK — CYTOKINETICS INC (CYTK) — 8-K filing

Items: 8.01

full page →edgar 8k ↗

Week of Jan 4, 2027

1
›Jan 4, 2027pdufa143dPDUFA — 2027-01-04

action date of January 4, 2027

full page →pdufa extract ↗

Week of Jan 18, 2027

1
›Jan 21, 2027pdufa160dPDUFA — 2027-01-21Ultragenyx Pharmaceutical Inc.

action date of Jan. 21, 2027

full page →pdufa extract ↗

Date TBD

17
›TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗
›TBDapprovalTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →OXCARBAZEPINE →fda approvals ↗
›RECRUITINGphase readoutNCT06924671: GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07542236: Hip and Ankle Mobility Rehabilitation for Soccer Players With Patellofemoral Pain

Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Definium Therapeutics, Inc.

Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06466434: Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06806709: Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07178509: A Study of SCAD Using Stress Contrast EchocardiographyMayo Clinic

Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection

full page →ctgov ↗
›COMPLETEDphase readoutNCT07403409: Scapular Repeated Contractions Facilitation Versus Hold-relax Techniques in Patients With Adhesive Capsulitis

Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06721663: Multisensory Environment Stimulation Therapy on Postural Control in Cerebral Palsy

Sponsor: October 6 University. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06624787: Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Sponsor: Liverpool School of Tropical Medicine. Phase: NA. Conditions: Crimean-Congo Haemorrhagic Fever

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07527221: Safety and Tolerability of ZE74-0282 in Healthy VolunteersCerta Therapeutics Pty Ltd

Sponsor: Eilean Therapeutics AU Pty Ltd. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07329114: Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)

Sponsor: Chandan Sen. Phase: NA. Conditions: Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT01778504: Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Neuropsychiatric Disorder, Neurological Disorder, Neurodevelopmental Disorder, Sleep

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05103033: Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)University of Washington

Sponsor: University of Washington. Phase: NA. Conditions: Mental Health Disorder

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06906952: A Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon Cancer

Sponsor: Nanchang University. Phase: NA. Conditions: Natural Orifice Specimen Extraction Surgery, Robotic Surgery, Short-term Outcomes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07281547: Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and PainMayo Clinic

Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Endometrial Carcinoma

full page →ctgov ↗
← prev
page 46 of 170
next →
$RARE26.86-0.37%
$ABBV250.25+0.60%
$NVS152.24-0.06%
$DFTX44.33+3.59%